These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29940988)

  • 1. Prolonged inhibition of class I PI3K promotes liver cancer stem cell expansion by augmenting SGK3/GSK-3β/β-catenin signalling.
    Liu F; Wu X; Jiang X; Qian Y; Gao J
    J Exp Clin Cancer Res; 2018 Jun; 37(1):122. PubMed ID: 29940988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PIK3C3 regulates the expansion of liver CSCs and PIK3C3 inhibition counteracts liver cancer stem cell activity induced by PI3K inhibitor.
    Liu F; Wu X; Qian Y; Jiang X; Wang Y; Gao J
    Cell Death Dis; 2020 Jun; 11(6):427. PubMed ID: 32513919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shp2 promotes liver cancer stem cell expansion by augmenting β-catenin signaling and predicts chemotherapeutic response of patients.
    Xiang D; Cheng Z; Liu H; Wang X; Han T; Sun W; Li X; Yang W; Chen C; Xia M; Liu N; Yin S; Jin G; Lee T; Dong L; Hu H; Wang H; Ding J
    Hepatology; 2017 May; 65(5):1566-1580. PubMed ID: 28059452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway.
    Ni CX; Qi Y; Zhang J; Liu Y; Xu WH; Xu J; Hu HG; Wu QY; Wang Y; Zhang JP
    Oncotarget; 2016 Nov; 7(48):79544-79556. PubMed ID: 27783993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enrichment of cancer stem cells via β-catenin contributing to the tumorigenesis of hepatocellular carcinoma.
    Pandit H; Li Y; Li X; Zhang W; Li S; Martin RCG
    BMC Cancer; 2018 Aug; 18(1):783. PubMed ID: 30075764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth differentiation factor 15 induces growth and metastasis of human liver cancer stem-like cells via AKT/GSK-3β/β-catenin signaling.
    Xu Q; Xu HX; Li JP; Wang S; Fu Z; Jia J; Wang L; Zhu ZF; Lu R; Yao Z
    Oncotarget; 2017 Mar; 8(10):16972-16987. PubMed ID: 28199981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3β and Nur77 to prevent β-catenin degradation.
    Lu WJ; Chua MS; Wei W; So SK
    Oncotarget; 2015 Oct; 6(30):29847-59. PubMed ID: 26359353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PAF enhances cancer stem cell properties via β-catenin signaling in hepatocellular carcinoma.
    Li M; Mu XD; Song JR; Zhai PT; Cheng Y; Le Y; Li ZB
    Cell Cycle; 2021 May; 20(10):1010-1020. PubMed ID: 33970778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erinacine Facilitates the Opening of the Mitochondrial Permeability Transition Pore Through the Inhibition of the PI3K/ Akt/GSK-3β Signaling Pathway in Human Hepatocellular Carcinoma.
    Zhou LJ; Mo YB; Bu X; Wang JJ; Bai J; Zhang JW; Cheng AB; Ma JH; Wang YW; Xie YX
    Cell Physiol Biochem; 2018; 50(3):851-867. PubMed ID: 30355923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-155 promotes epithelial-mesenchymal transition in hepatocellular carcinoma cells through the activation of PI3K/SGK3/β-catenin signaling pathways.
    Kong X; Liu F; Gao J
    Oncotarget; 2016 Oct; 7(40):66051-66060. PubMed ID: 27602769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer Effect of Polyphyllin I in Suppressing Stem Cell-Like Properties of Hepatocellular Carcinoma via the AKT/GSK-3
    Liao M; Du H; Wang B; Huang J; Huang D; Tong G
    Oxid Med Cell Longev; 2022; 2022():4031008. PubMed ID: 36317061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation therapy of hepatocellular carcinoma by inhibiting the activity of AKT/GSK-3β/β-catenin axis and TGF-β induced EMT with sophocarpine.
    Zhang PP; Wang PQ; Qiao CP; Zhang Q; Zhang JP; Chen F; Zhang X; Xie WF; Yuan ZL; Li ZS; Chen YX
    Cancer Lett; 2016 Jun; 376(1):95-103. PubMed ID: 26945965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA THOR promotes liver cancer stem cells expansion via β-catenin pathway.
    Cheng Z; Lei Z; Yang P; Si A; Xiang D; Zhou J; Hüser N
    Gene; 2019 Feb; 684():95-103. PubMed ID: 30359743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteopontin Promotes Colorectal Cancer Cell Invasion and the Stem Cell-Like Properties through the PI3K-AKT-GSK/3β-β/Catenin Pathway.
    Cheng Y; Wen G; Sun Y; Shen Y; Zeng Y; Du M; Zhu G; Wang G; Meng X
    Med Sci Monit; 2019 Apr; 25():3014-3025. PubMed ID: 31017126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional role of SGK3 in PI3K/Pten driven liver tumor development.
    Cao H; Xu Z; Wang J; Cigliano A; Pilo MG; Ribback S; Zhang S; Qiao Y; Che L; Pascale RM; Calvisi DF; Chen X
    BMC Cancer; 2019 Apr; 19(1):343. PubMed ID: 30975125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
    Wang D; Fu L; Sun H; Guo L; DuBois RN
    Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EPHB2 Activates β-Catenin to Enhance Cancer Stem Cell Properties and Drive Sorafenib Resistance in Hepatocellular Carcinoma.
    Leung HW; Leung CON; Lau EY; Chung KPS; Mok EH; Lei MML; Leung RWH; Tong M; Keng VW; Ma C; Zhao Q; Ng IOL; Ma S; Lee TK
    Cancer Res; 2021 Jun; 81(12):3229-3240. PubMed ID: 33903122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omega-3 polyunsaturated fatty acids inhibit hepatocellular carcinoma cell growth through blocking beta-catenin and cyclooxygenase-2.
    Lim K; Han C; Dai Y; Shen M; Wu T
    Mol Cancer Ther; 2009 Nov; 8(11):3046-55. PubMed ID: 19887546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical exercise suppresses hepatocellular carcinoma progression by alleviating hypoxia and attenuating cancer stemness through the Akt/GSK-3β/β-catenin pathway.
    Xiao CL; Zhong ZP; Lü C; Guo BJ; Chen JJ; Zhao T; Yin ZF; Li B
    J Integr Med; 2023 Mar; 21(2):184-193. PubMed ID: 36781361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing of lemur tyrosine kinase 2 restricts the proliferation and invasion of hepatocellular carcinoma through modulation of GSK-3β/Wnt/β-catenin signaling.
    Zhao G; Song Y; Dong L; Shi H; Li H; Yang L; Wang J
    Biochem Biophys Res Commun; 2019 Oct; 517(4):722-728. PubMed ID: 31395338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.